Search Results - "Davis, Vicki"

Development of topical ophthalmic In Situ gel-forming estradiol delivery system intended for the prevention of age-related cataracts by Kotreka, Udaya K, Davis, Vicki L, Adeyeye, Moji C

“…The goal of this study was to develop and characterize an ion-activated in situ gel-forming estradiol (E2) solution eye drops intended for the prevention of…”
Get full text

The Banff Working Group Classification of Definitive Polyomavirus Nephropathy: Morphologic Definitions and Clinical Correlations by Nickeleit, Volker, Singh, Harsharan K, Randhawa, Parmjeet, Drachenberg, Cinthia B, Bhatnagar, Ramneesh, Bracamonte, Erika, Chang, Anthony, Chon, W James, Dadhania, Darshana, Davis, Vicki G, Hopfer, Helmut, Mihatsch, Michael J, Papadimitriou, John C, Schaub, Stefan, Stokes, Michael B, Tungekar, Mohammad F, Seshan, Surya V

“…Polyomavirus nephropathy (PVN) is a common viral infection of renal allografts, with biopsy-proven incidence of approximately 5%. A generally accepted…”
Get full text

Biological effects of melatonin on osteoblast/osteoclast cocultures, bone, and quality of life: Implications of a role for MT2 melatonin receptors, MEK1/2, and MEK5 in melatonin‐mediated osteoblastogenesis by Maria, Sifat, Samsonraj, Rebekah M., Munmun, Fahima, Glas, Jessica, Silvestros, Maria, Kotlarczyk, Mary P., Rylands, Ryan, Dudakovic, Amel, Wijnen, Andre J., Enderby, Larry T., Lassila, Holly, Dodda, Bala, Davis, Vicki L., Balk, Judy, Burow, Matt, Bunnell, Bruce A., Witt‐Enderby, Paula A.

“…The Melatonin Osteoporosis Prevention Study (MOPS) demonstrated that nightly melatonin resulted in a time‐dependent decrease in equilibrium ratios of serum…”
Get full text

The 2018 Banff Working Group classification of definitive polyomavirus nephropathy: A multicenter validation study in the modern era by Nickeleit, Volker, Singh, Harsharan K., Dadhania, Darshana, Cornea, Virgilius, El‐Husseini, Amr, Castellanos, Ana, Davis, Vicki G., Waid, Thomas, Seshan, Surya V.

“…Polyomavirus nephropathy (PVN) remained inadequately classified until 2018 when the Banff Working Group published a new 3‐tier morphologic classification…”
Get full text

Validation of a Computerized test of Functional Capacity by Keefe, Richard S.E, Davis, Vicki G, Atkins, Alexandra S, Vaughan, Adam, Patterson, Tom, Narasimhan, Meera, Harvey, Philip D

“…Abstract Regulatory guidance for schizophrenia cognition clinical trials requires that the assessment of cognitive change is accompanied by a functionally…”
Get full text

Placebo Response and Practice Effects in Schizophrenia Cognition Trials by Keefe, Richard S E, Davis, Vicki G, Harvey, Philip D, Atkins, Alexandra S, Haig, George M, Hagino, Owen, Marder, Stephen, Hilt, Dana C, Umbricht, Daniel

“…Patients' previous experience with performance-based cognitive tests in clinical trials for cognitive impairment associated with schizophrenia can create…”
Get more information

Classifying Polyomavirus Nephropathy: The "Banff" Initiative by Nickeleit, Volker, Singh, H K, Davis, Vicki G, Seshan, Surya V

Get full text

The Urinary Polyomavirus-Haufen Test: A Highly Predictive Non-Invasive Biomarker to Distinguish "Presumptive" from "Definitive" Polyomavirus Nephropathy: How to Use It-When to Use It-How Does It Compare to PCR Based Assays? by Nickeleit, Volker, Davis, Vicki G, Thompson, Bawana, Singh, Harsharan K

“…"Definitive" biopsy proven polyomavirus nephropathy (PyVN), usually caused by BK polyomavirus (BKPyV), remains a significant infection of kidney transplants…”
Get full text

Psychometric characteristics of the MATRICS Consensus Cognitive Battery in a large pooled cohort of stable schizophrenia patients by Georgiades, Anastasia, Davis, Vicki G, Atkins, Alexandra S, Khan, Anzalee, Walker, Trina W, Loebel, Antony, Haig, George, Hilt, Dana C, Dunayevich, Eduardo, Umbricht, Daniel, Sand, Michael, Keefe, Richard S.E

“…Abstract The MATRICS Consensus Cognitive Battery (MCCB) was developed to assess cognitive treatment effects in schizophrenia clinical trials, and is considered…”
Get full text

Increasing Incidence of Inadequate Kidney Biopsy Samples Over Time: A 16-Year Retrospective Analysis From a Large National Renal Biopsy Laboratory by Nissen, Caleb J., Moreno, Vanessa, Davis, Vicki G., Walker, Patrick D.

“…Renal biopsy remains an essential tool for the diagnosis and treatment of patients with medical kidney disease. Recently, there has been a perceived change in…”
Get full text

Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study by Daumit, Gail L, Goff, Donald C, Meyer, Jonathan M, Davis, Vicki G, Nasrallah, Henry A, McEvoy, Joseph P, Rosenheck, Robert, Davis, Sonia M, Hsiao, John K, Stroup, T. Scott, Lieberman, Jeffrey A

“…Abstract Objective Persons with schizophrenia die earlier than the general population, in large part due to cardiovascular disease. The study objective was to…”
Get full text

Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1 by Meyer, Jonathan M, Davis, Vicki G, Goff, Donald C, McEvoy, Joseph P, Nasrallah, Henry A, Davis, Sonia M, Rosenheck, Robert A, Daumit, Gail L, Hsiao, John, Swartz, Marvin S, Stroup, T. Scott, Lieberman, Jeffrey A

“…Abstract Background The metabolic syndrome (MS) is associated with increased risk for diabetes mellitus and coronary heart disease, and is highly prevalent…”
Get full text

Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale by Keefe, Richard S.E, Davis, Vicki G, Spagnola, Nathan B, Hilt, Dana, Dgetluck, Nancy, Ruse, Stacy, Patterson, Thomas D, Narasimhan, Meera, Harvey, Philip D

“…Abstract Cognitive functioning can be assessed with performance-based assessments such as neuropsychological tests and with interview-based assessments. Both…”
Get full text

Platelet-rich preparations to improve healing. Part II: platelet activation and enrichment, leukocyte inclusion, and other selection criteria by Davis, Vicki L, Abukabda, Alaeddin B, Radio, Nicholas M, Witt-Enderby, Paula A, Clafshenkel, William P, Cairone, J Vito, Rutkowski, James L

“…Multiple platelet-rich preparations have been reported to improve wound and bone healing, such as platelet-rich plasma (PRP) and platelet rich fibrin (PRF)…”
Get full text

Inflammatory Markers in Schizophrenia: Comparing Antipsychotic Effects in Phase 1 of the Clinical Antipsychotic Trials of Intervention Effectiveness Study by Meyer, Jonathan M, McEvoy, Joseph P, Davis, Vicki G, Goff, Donald C, Nasrallah, Henry A, Davis, Sonia M, Hsiao, John K, Swartz, Marvin S, Stroup, T. Scott, Lieberman, Jeffrey A

“…Background C-reactive protein (CRP), intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin are systemic…”
Get full text

The Brief Assessment of Cognition In Affective Disorders (BAC-A):Performance of patients with bipolar depression and healthy controls by Keefe, Richard S.E, Fox, Kolleen H, Davis, Vicki G, Kennel, Courtney, Walker, Trina M, Burdick, Katherine E, Harvey, Philip D

“…Abstract Background Cognitive deficits in bipolar disorder are significant enough to impact everyday functioning. A key question for treatments aimed at…”
Get full text

Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy by Witt-Enderby, Paula A., Radio, Nicholas M., Doctor, John S., Davis, Vicki L.

“…:  Melatonin's therapeutic potential is grossly underestimated because its functional roles are diverse and its mechanism(s) of action are complex and varied…”
Get full text

Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer by Dodda, Balasunder R, Bondi, Corry D, Hasan, Mahmud, Clafshenkel, William P, Gallagher, Katie M, Kotlarczyk, Mary P, Sethi, Shalini, Buszko, Ethan, Latimer, Jean J, Cline, J Mark, Witt-Enderby, Paula A, Davis, Vicki L

“…Melatonin has numerous anti-cancer properties reported to influence cancer initiation, promotion, and metastasis. With the need for effective hormone therapies…”
Get full text

Platelet-rich preparations to improve healing. Part I: workable options for every size practice by Davis, Vicki L, Abukabda, Alaeddin B, Radio, Nicholas M, Witt-Enderby, Paula A, Clafshenkel, William P, Cairone, J Vito, Rutkowski, James L

“…Numerous studies have demonstrated that platelet-rich preparations applied to surgical sites, injuries, or wounds are a safe and effective way to promote soft…”
Get full text

Effects on bone by the light/dark cycle and chronic treatment with melatonin and/or hormone replacement therapy in intact female mice by Witt-Enderby, Paula A., Slater, John P., Johnson, Nakpangi A., Bondi, Corry D., Dodda, Balasunder R., Kotlarczyk, Mary P., Clafshenkel, William P., Sethi, Shalini, Higginbotham, Suzanne, Rutkowski, James L., Gallagher, Katie M., Davis, Vicki L.

“…:  In this study, the effects of the light/dark cycle, hormone replacement therapy (HRT), and nocturnal melatonin supplementation on osteogenic markers and…”
Get full text